http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090018707-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2007-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e0fc4673162f208285ca87a08d243d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9af77aca5f5ac48833873134fe7c55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c615d9f718c5e65ecf3a300bb4883884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65638635268521b1fdc579c42df5f56f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2f76a9bd1e9a5e70124483c5d5dff4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5ba46115a984b90e37ff0bdb2eeb374 |
| publicationDate | 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090018707-A |
| titleOfInvention | Pyrrolidine derivatives useful as bace inhibitors |
| abstract | Novel 3-mono, 3,4-disubstituted and 3,4,4-trisubstituted pyrrolidine compounds; For use in diagnostic and therapeutic treatment of warm-blooded animals, in particular dependent on the activity of beta-secretase, and / or the production of beta-amyloid and subsequent aggregation into oligomers and fibrils (= disorders) These compounds for treatment; The use of compounds of this class for the manufacture of pharmaceutical preparations for the treatment of diseases dependent on the activity of beta-secretase and / or the production of beta-amyloid and subsequent aggregation into oligomers and fibrils; The use of compounds of this class in the treatment of diseases dependent on the activity of beta-secretase and / or the production of beta-amyloid and subsequent aggregation into oligomers and fibrils; Pharmaceutical formulations comprising the substituted pyrrolidine compounds and / or methods of treatment comprising administration of the substituted pyrrolidine compounds are described. Substituted pyrrolidine compounds are especially compounds of formula (I) wherein the substituents are as described in the specification.n n n <Formula I> |
| priorityDate | 2006-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.